publication venue for
- Tumorous expression of NAC1 restrains antitumor immunity through the LDHA-mediated immune evasion.. 10:e004856-e004856. 2022
- eEF2K promotes PD-L1 stabilization through inactivating GSK3 in melanoma.. 10:e004026-e004026. 2022
- Association of antibiotic treatment with immune-related adverse events in patients with cancer receiving immunotherapy.. 10:e003779-e003779. 2022
- Live attenuated bacterium limits cancer resistance to CAR-T therapy by remodeling the tumor microenvironment.. 10:e003760-e003760. 2022
- A NOVEL NUCLEAR RECEPTOR 4A1 (NR4A1) ANTAGONISTS ATTENUATES T-CELL EXHAUSTION IN COLORECTAL CANCER. 9:A761-A762. 2021
- IMMUNOMODULATION BY TARGETING PDL-1 IN COLON CANCER USING NUCLEAR RECEPTOR 4A1 (NR4A1) ANTAGONISTS. 9:A754-A755. 2021
- Ovarian cancer stem cells and macrophages reciprocally interact through the WNT pathway to promote pro-tumoral and malignant phenotypes in 3D engineered microenvironments.. 7:190. 2019
- Stem cell-derived tissue- associated regulatory T cells ameliorate the development of autoimmune arthritis. 3:p21. 2015
- PBRM1 loss defines distinct tumor phenotype associated with immunotherapy resistance in renal cell carcinoma 2019